Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node Hyperplasia, Giant”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06643091
What this trial is testing

Nintedanib Treatment in Unicentric Castleman Disease

Who this might be right for
Castleman Disease
Assistance Publique - Hôpitaux de Paris 13
Not applicableStudy completedNCT05440305
What this trial is testing

Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Who this might be right for
Castleman DiseaseUnicentric Castleman DiseaseSurgery
Charles University, Czech Republic 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing

Anti-IL-6R mAb Injection in Patients With iMCD

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT01400503
What this trial is testing

Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 60
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Not applicableLooking for participantsNCT00006518
What this trial is testing

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Who this might be right for
HIVKaposi's SarcomaLymphomas+2 more
National Cancer Institute (NCI) 1,029
Not applicableLooking for participantsNCT04968288
What this trial is testing

Natural History of KSHV-Associated Multicentric Castleman s Disease

Who this might be right for
Multicentric Castleman s Disease
National Cancer Institute (NCI) 195
Testing effectiveness (Phase 2)Study completedNCT01441063
What this trial is testing

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseMulticentric Castleman DiseaseGiant Lymph Node Hyperplasia
National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000
Not applicableWithdrawnNCT02871050
What this trial is testing

Castleman Disease Collaborative Network Biobank

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
Castleman Disease Collaborative Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT04585893
What this trial is testing

Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Who this might be right for
Multicentric Castleman Disease
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00127569
What this trial is testing

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Who this might be right for
HIV InfectionsGiant Lymph Node Hyperplasia
French National Agency for Research on AIDS and Viral Hepatitis 25
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Not applicableLooking for participantsNCT05200715
What this trial is testing

AutoInflammatory Disease Alliance Registry (AIDA)

Who this might be right for
Hereditary Autoinflammatory DiseasesSchnitzler SyndromeBehcet Syndrome+8 more
University of Siena 3,500
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Load More Results